Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1233-1238

  Upadhyaya, Pramod ^a   Carmella, Steven G ^a   Guengerich, F Peter ^b   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL;

ANIMAL TISSUE; ARTICLE; CYTOSOL; ENANTIOMER; ERYTHROCYTE; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER; LIVER CYTOSOL; LIVER MICROSOME; LUNG; MALE; METABOLISM; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034125713     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.233     Document Type: Article

References (37)

1. Hecht, S.S. and Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
2. Hecht, S.S. (1998) Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11, 559-603.
3. Hoffmann, D., Brunnemann, K.D., Prokopczyk, B. and Djordjevic, M.V. (1994) Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity and relevance to humans. J. Toxicol. Environ. Health, 41, 1-52.
4. Spiegelhalder, B. and Bartsch, H. (1996) Tobacco-specific nitrosamines. Eur. J. Cancer Prev., 5, 33-38.
5. Hecht, S.S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst., 91, 1194-1210.
6. Magee, P.N. (1996) Nitrosamines and human cancer: introduction and overview. Eur. J. Cancer Prev., 5, 7-10.
7. Bartsch, H. and Spiegelhalder, B. (1996) Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur. J. Cancer Prev., 5, 11-18.
8. Hecht, S.S., Spratt, T.E. and Trushin, N. (1997) Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis, 18, 1851-1854.
9. Upadhyaya, P., Kenney, P.M.J., Hochalter, J.B., Wang, M. and Hecht, S.S. (1999) Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) enantiomers and metabolites in the A/J mouse. Carcinogenesis, 20, 1577-1582.
10. Carmella, S.G., Ye, M., Upadhyaya, P. and Hecht, S.S. (1999) Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine. Cancer Res., 59, 3602-3605.
11. Hecht, S.S., Lin, D. and Castonguay, A. (1983) Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis, 4, 305-310.
12. Hecht, S.S., Young, R. and Chen, C.B. (1980) Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res., 40, 4144-4150.
13. Castonguay, A., Tjälve, H., Trushin, N. and Hecht, S.S. (1984) Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57B1 mice. J. Natl Cancer Inst., 72, 1117-1126.
14. Peterson, L.A., Ng, D.K., Stearns, R.A. and Hecht, S.S. (1994) Formation of NADP(H) analogs of tobacco specific nitrosamines in rat liver and pancreatic microsomes. Chem. Res. Toxicol., 7, 599-608.
15. Loozen, H.J.J., Godefroi, E.F. and Besters, J.S.M.M. (1975) A novel and efficient route to 5-arylated δ-lactones. J. Org. Chem., 40, 892-894.
16. McKennis, H., Schwartz, S.L., Turnbull, L.B., Tamaki, E. and Bowman, E.R. (1964) The metabolic formation of γ-(3-pyridyl)-γ-hydroxybutyric acid and its possible intermediary role in the mammalian metabolism of nicotine. J. Biol. Chem., 239, 3981-3989.
17. Spratt, T.E., Peterson, L.A., Confer, W.L. and Hecht, S.S. (1990) Solvolysis of model compounds for α-hydroxylation of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophiles. Chem. Res. Toxicol., 3, 350-356.
18. Guengerich, F.P. (1994) Analysis and characterization of enzymes. In Hayes, A.W. (ed.). Principles and Methods of Toxicology. Raven Press, New York, pp. 1259-1313.
19. Murphy, S.E. and Coletta, K.A. (1993) Two types of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells. Cancer Res., 53, 777-783.
20. Carmella, S.G., Akerkar, S. and Hecht, S.S. (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53, 721-724.
21. Staretz, M.E., Murphy, S.E., Nunes, M.G., Koehl, W., Amin, S., Koenig, L., Guengerich, F.P. and Hecht, S.S. (1997) Comparative metabolism of the tobacco smoke carcinogens benzo(a)pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and N′-nitrosonornicotine in human hepatic microsomes. Drug Metab. Dispos., 25, 154-162.
22. Staretz, M.E., Koenig, L. and Hecht, S.S. (1997) Effects of long term phenethyl isothiocyanate treatment on microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis, 18, 1715-1722.
23. Hecht, S.S., Trushin, N., Reid-Quinn, C.A., Burak, E.S., Jones, A.B., Southers, J.L., Gombar, C.T., Carmella, S.G., Anderson, L.M. and Rice, J.M. (1993) Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis, 14, 229-236.
24. Carmella, S.G., Akerkar, S., Richie, J.P.Jr and Hecht, S.S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomarkers Prev., 4, 635-642.
25. Ren, Q., Murphy, S.E., Dannenberg, A.J., Park, J.Y., Tephly, T.R. and Lazarus, P. (1999) Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by rat UDP-glucuronosyltransferase 2B1. Drug Metab. Disp., 27, 1010-1016.
26. Morse, M.A., Eklind, K.I., Toussaint, M., Amin, S.G. and Chung, F.-L. (1990) Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis, 11, 1819-1823.
27. Felsted, R.L. and Bachur, N.R. (1980) Mammalian carbonyl reductases. Drug Metab. Rev., 11, 1-60.
28. Jez, J.M., Flynn, T.G. and Penning, T.M. (1996) A nomenclature system for the aldo-keto reductase superfamily. In Weiner, H., Lindahl, R., Crabb, D.W. and Flynn, T.G. (eds), Enzymology and Molecular Biology of Carbonyl Metabolism. Plenum Press, New York, pp. 579-589.
29. Dow, J. and Berg, C. (1995) Stereoselectivity of the carbonyl reduction of dolasetron in rats, dogs and humans. Chirality, 7, 342-348.
30. Eyles, D.W. and Pond, S.M. (1992) Stereospecific reduction of haloperidol in human tissues. Biochem. Pharmacol., 44, 867-871.
31. 14C] fenofibrate in laboratory animals and humans. Chirality, 1, 197-201.
32. Prelusky, D.B., Couts, R.T. and Pasutto, F.M. (1982) Stereospecific metabolic reduction of ketones. J. Pharmaceut. Sci., 71, 1390-1393.
33. Prelog, V. (1964) Specification of the stereospecificity of some oxidoreductuses by diamant lattice sections. Pure Appl. Chem., 9, 119-130.
34. Trushin, N. and Hecht, S.S. (1999) Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats. Chem. Res. Toxicol., 12, 164-171.
35. Hecht, S.S., Hatsukami, D.K., Bonilla, L.E. and Hochalter, J.B. (1999) Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem. Res. Toxicol., 12, 172-179.
36. Maser, E., Richter, E. and Friebertshauser, J. (1996) The identification of 11-β-hydroxysteriod dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem., 238, 484-489.
37. Maser, E. (1998) 11-β-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes. Cancer Res., 58, 2996-3003.